Abstract:BACKGROUND:Expansions of myeloid-derived suppressor cells (MDSCs) have been identified in human solid tumors, including colorectal cancer (CRC). However, the nature of these tumor-associated MDSCs and their interactions with tumor cells in CRC are still poorly understood.METHODS:The percentages and phenotype of MDSCs in peripheral blood and tumorous and paraneoplastic tissues from CRC patients, as well as the clinical relevance of these MDSCs, were assessed. Age-matched healthy donors were included as controls. The interaction between MDSCs and T cells or tumor cells was investigated in a coculture system in vitro, and the molecular mechanism of the effect of MDSCs on T cells or tumor cells was evaluated.RESULTS:We discovered that CRC patients had elevated levels of CD33(+)CD11b(+)HLA-DR(-) MDSCs in primary tumor tissues and in peripheral blood, and the elevated circulating MDSCs were correlated with advanced TNM stages and lymph node metastases. Radical resection significantly decreases the proportions of circulating MDSCs and CD4(+)CD25(high)FOXP3(+) regulatory T cells. In vitro, CRC cells mediate the promotion of MDSC induction. Moreover, these tumor-induced MDSCs could suppress T cell proliferation and promote CRC cell growth via cell-to-cell contact. Such effects could be abolished by the inhibition of oxidative metabolism, including the production of nitric oxide (NO), and reactive oxygen species (ROS).CONCLUSIONS:Our results reveal the functional interdependence between MDSCs, T cells and cancer cells in CRC pathogenesis. Understanding the impact of MDSCs on T cells and tumor cells will be helpful to establish an immunotherapeutic strategy in CRC patients.

Function of reactive oxygen species in myeloid-derived suppressor cells

Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword

Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies

Role of reactive oxygen species in myelodysplastic syndromes

Glycolysis Regulates the Expansion of Myeloid-Derived Suppressor Cells in Tumor-Bearing Hosts Through Prevention of ROS-mediated Apoptosis.

Myeloid-Derived Suppressor Cells in Solid Tumors

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer

Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation

Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment

Tumor-induced Myeloid-Derived Suppressor Cells Promote Tumor Progression Through Oxidative Metabolism in Human Colorectal Cancer

Metabolic Regulation Of Myeloid-Derived Suppressor Cell Function In Cancer

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy

Myeloid-Derived Suppressor Cells in Major Depression Patients Suppress T-Cell Responses Through the Production of Reactive Oxygen Species

Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in cancer

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy

ROS Fine-Tunes the Function and Fate of Immune Cells

Myeloid-Derived Suppressor Cells: Roles In The Tumor Microenvironment And Tumor Radiotherapy

Myeloid-derived suppressor cells as regulators of the immune system

Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment